Structural features of coronavirus SARS-CoV-2 spike protein: targets for vaccination
Various human pathogenic viruses employ envelope glycoproteins for host cell receptor recognition and binding, membrane fusion and viral entry. The spike (S) glycoprotein of betacoronavirus SARS-CoV-2 is a homotrimeric class I fusion protein that exists in a metastable conformation for cleavage by h...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
6 July 2020
|
| In: |
Life sciences
Year: 2020, Jahrgang: 257 |
| ISSN: | 1879-0631 |
| DOI: | 10.1016/j.lfs.2020.118056 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.lfs.2020.118056 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0024320520308079 
|
| Verfasserangaben: | Ariane Sternberg, Cord Naujokat |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 173842636X | ||
| 003 | DE-627 | ||
| 005 | 20220819020951.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201111s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.lfs.2020.118056 |2 doi | |
| 035 | |a (DE-627)173842636X | ||
| 035 | |a (DE-599)KXP173842636X | ||
| 035 | |a (OCoLC)1341376176 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Sternberg, Ariane |e VerfasserIn |0 (DE-588)1219091588 |0 (DE-627)1734807040 |4 aut | |
| 245 | 1 | 0 | |a Structural features of coronavirus SARS-CoV-2 spike protein |b targets for vaccination |c Ariane Sternberg, Cord Naujokat |
| 264 | 1 | |c 6 July 2020 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.11.2020 | ||
| 520 | |a Various human pathogenic viruses employ envelope glycoproteins for host cell receptor recognition and binding, membrane fusion and viral entry. The spike (S) glycoprotein of betacoronavirus SARS-CoV-2 is a homotrimeric class I fusion protein that exists in a metastable conformation for cleavage by host cell proteases furin and TMPRSS2, thereby undergoing substantial structural rearrangement for ACE2 host cell receptor binding and subsequent viral entry by membrane fusion. The S protein is densely decorated with N-linked glycans protruding from the trimer surface that affect S protein folding, processing by host cell proteases and the elicitation of humoral immune response. Deep insight into the sophisticated structure of SARS-CoV-2 S protein may provide a blueprint for vaccination strategies, as reviewed herein. | ||
| 650 | 4 | |a ACE2 | |
| 650 | 4 | |a Coronavirus SARS-CoV-2 | |
| 650 | 4 | |a Immune response | |
| 650 | 4 | |a Protein structure | |
| 650 | 4 | |a Receptor binding domain | |
| 650 | 4 | |a Spike protein | |
| 650 | 4 | |a Vaccination | |
| 650 | 4 | |a Viral fusion protein | |
| 700 | 1 | |a Naujokat, Cord |d 1964- |e VerfasserIn |0 (DE-588)123190592 |0 (DE-627)082401616 |0 (DE-576)184229537 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Life sciences |d New York, NY [u.a.] : Elsevier Science, 1963 |g 257(2020) Artikel-Nummer 118056, 7 Seiten |h Online-Ressource |w (DE-627)320515605 |w (DE-600)2013911-1 |w (DE-576)09095503X |x 1879-0631 |7 nnas |a Structural features of coronavirus SARS-CoV-2 spike protein targets for vaccination |
| 773 | 1 | 8 | |g volume:257 |g year:2020 |g extent:7 |a Structural features of coronavirus SARS-CoV-2 spike protein targets for vaccination |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.lfs.2020.118056 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0024320520308079 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201111 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 123190592 |a Naujokat, Cord |m 123190592:Naujokat, Cord |d 50000 |e 50000PN123190592 |k 0/50000/ |p 2 |y j | ||
| 999 | |a KXP-PPN173842636X |e 3798692246 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"id":{"issn":["1879-0631"],"eki":["320515605"],"zdb":["2013911-1"]},"origin":[{"publisherPlace":"New York, NY [u.a.]","dateIssuedDisp":"1963-","publisher":"Elsevier Science","dateIssuedKey":"1963"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Life sciences","subtitle":"including pharmacology letters","title_sort":"Life sciences"}],"language":["eng"],"recId":"320515605","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Structural features of coronavirus SARS-CoV-2 spike protein targets for vaccinationLife sciences","note":["Gesehen am 21.02.20"],"titleAlt":[{"title":"Pharmacology letters"}],"part":{"volume":"257","text":"257(2020) Artikel-Nummer 118056, 7 Seiten","extent":"7","year":"2020"},"pubHistory":["[1.]1962(1963) -"]}],"physDesc":[{"extent":"7 S."}],"name":{"displayForm":["Ariane Sternberg, Cord Naujokat"]},"id":{"doi":["10.1016/j.lfs.2020.118056"],"eki":["173842636X"]},"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"6 July 2020"}],"recId":"173842636X","language":["eng"],"note":["Gesehen am 11.11.2020"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"family":"Sternberg","given":"Ariane","roleDisplay":"VerfasserIn","display":"Sternberg, Ariane","role":"aut"},{"given":"Cord","family":"Naujokat","role":"aut","display":"Naujokat, Cord","roleDisplay":"VerfasserIn"}],"title":[{"title_sort":"Structural features of coronavirus SARS-CoV-2 spike protein","subtitle":"targets for vaccination","title":"Structural features of coronavirus SARS-CoV-2 spike protein"}]} | ||
| SRT | |a STERNBERGASTRUCTURAL6202 | ||